(Q24234607)

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Phytochemicals from Phyllanthus niruri Linn. and their pharmacological properties: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

A review of the plants of the genus Phyllanthus: their chemistry, pharmacology, and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Differential inhibition of reverse transcriptase and cellular DNA polymerase-alpha activities by lignans isolated from Chinese herbs, Phyllanthus myrtifolius Moon, and tannins from Lonicera japonica Thunb and Castanopsis hystrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Vaccines for preventing hepatitis B in health-care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Practical aspects in data monitoring: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Uncertainty method improved on best-worst case analysis in a binary meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Assessment of total economic burden of chronic hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Molecular phylogenetics of Phyllanthaceae inferred from five genes (plastid atpB, matK, 3'ndhF, rbcL, and nuclear PHYC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Comparative pharmacognostic studies of three Phyllanthus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Phyllanthus amarus down-regulates hepatitis B virus mRNA transcription and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Genus Phyllanthus for chronic hepatitis B virus infection: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Management of chronic hepatitis B: experience from China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/14651858.CD009004

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2762871

OpenCitations bibliographic resource ID

2762871

1 reference